The detection of a subatomic particle in 2023 sent shockwaves through the global physics community, as a single neutrino struck…
Read More
Rocket Pharmaceuticals Secures Landmark FDA Approval for Kresladi, Ushering in a New Era for Ultra-Rare Immune Disease Treatment
The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Rocket Pharmaceuticals’ Kresladi (marnetegragene autotemcel), a groundbreaking gene…
Read More
Development of an ultra-sensitive human cardiac troponin I sandwich ELISA
In a significant advancement poised to reshape the landscape of cardiac biomarker detection, Exazym®’s innovative BOLD (Binding Oligo Ladder Detection)…
Read More
